Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin.
Chromosomal aberrations were evaluated in cultures of human peripheral lymphocytes from eight healthy donors, exposed to the antimicrobial enrofloxacin (EFX) or to its major metabolite ciprofloxacin (CFX). In both treatments cultures revealed an increase in the chromosomal aberration level, detected as chromatid and chromosome breaks and gaps. Control cultures analysis revealed 3.6 +/- 0.6 chromosomal aberrations per 100 cells while treated cultures exhibited 8.3 +/- 0.8 and 9.6 +/- 1.2 aberrations at 5 and 50 microg/ml of EFX respectively. In CFX treated cultures it was found 5.6 +/- 1.3 and 7.7 +/- 3.5 aberrations/100 cells at 5 and 25 microg/ml antimicrobial concentration. These results suggested a genotoxic effect of EFX and CFX in the system used (P < 0.001). A reduction in the mitotic index and fuzzy metaphases were observed at 50 microg/ml of CFX, indicating a cytotoxic effect produced by this antimicrobial.
Facultad de Agronomía y Veterinaria, UNRC, Río Cuarto, Argentina.
N
N
Gorla
H
H
García Ovando
I
I
Larripa
D000328:Adult; D000890:Anti-Infective Agents / Q000633:toxicity*; D002478:Cells, Cultured; D002869:Chromosome Aberrations / Q000502:physiology*; D002939:Ciprofloxacin / Q000633:toxicity*; D000077422:Enrofloxacin; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000187:drug effects / Q000648:ultrastructure*; D008297:Male; D008875:Middle Aged; D015363:Quinolones / Q000633:toxicity*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D000077422:Enrofloxacin; D002939:Ciprofloxacin